Evidence map›Paper›PMID 26800092›Full record

ReviewMuscle & nerve2016

A protocol to develop clinical guidelines for inclusion-body myositis.

Katherine L Jones, Thomas Sejersen, Anthony A Amato, David Hilton-Jones, Jens Schmidt, Amanda C Wallace, Umesh A Badrising, Michael R Rose, IBM Guideline Development Group

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Muscle & nerve, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Inclusion Body Myositis: Update on Pathogenesis and Treatment.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katherine L JonesDepartment of Neurology, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK.
Thomas SejersenDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Anthony A AmatoDepartment of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
David Hilton-JonesDepartment of Neurology, John Radcliffe Hospital, Oxford, UK.
Jens SchmidtUniversity Medical Center Göttingen, Göttingen, Germany.
Amanda C WallaceMRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
Umesh A BadrisingDepartment of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
Michael R RoseDepartment of Neurology, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK.
IBM Guideline Development Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInclusion-body myositis (IBM) is a late-onset idiopathic inflammatory myopathy associated with selective and progressive muscle weakness and atrophy. Current clinical management of IBM is largely supportive due to its uncertain etiology and lack of effective treatment. Establishing a consensus of opinion on questions relating to diagnosis and management of IBM is expected to help reduce inconsistencies in the care and resources allocated to those living with this condition.

methodsA protocol has been developed to produce best practice clinical guidelines for IBM based on a combination of published research and expert consensus.

conclusionsIn this study we describe the proposed protocol for developing methods for producing robust and transparent clinical guidance on aspects of diagnosis, drug treatment, physical and practical management, respiration, nutrition and cardiac management, psychosocial management, and multidisciplinary care.

Indexed as

Clinical Trials as TopicHumansMyositisMyositis, Inclusion BodyPractice Guidelines as TopicdiagnosisguidelinesIBMmanagementprotocol

Identifiers

PMID26800092
PMCPMC5067551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.